XML 15 R6.htm IDEA: XBRL DOCUMENT v3.26.1
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Class B Ordinary Shares [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Jan. 28, 2025 $ 0 $ 0 $ 0 $ 0
Beginning balance (in Shares) at Jan. 28, 2025 0      
Issuance of Class B ordinary shares to Sponsor [1],[2] $ 575 24,425 0 25,000
Issuance of Class B ordinary shares to Sponsor (in Shares) [1],[2] 5,750,000      
Balance end at Mar. 31, 2025 $ 575 24,425 0 25,000
Balance end (in Shares) at Mar. 31, 2025 5,750,000      
Net income       0
Balance end at Jun. 30, 2025 $ 575 24,425 0 25,000
Balance end (in Shares) at Jun. 30, 2025 5,750,000      
Beginning balance at Dec. 31, 2025 $ 500 0 404,179 404,679
Beginning balance (in Shares) at Dec. 31, 2025 5,000,000      
Accretion of carrying value to redemption value $ 0 0 (1,569,248) (1,569,248)
Net income 0 0 1,601,866 1,601,866
Balance end at Mar. 31, 2026 $ 500 0 436,797 437,297
Balance end (in Shares) at Mar. 31, 2026 5,000,000      
Beginning balance at Dec. 31, 2025 $ 500 0 404,179 404,679
Beginning balance (in Shares) at Dec. 31, 2025 5,000,000      
Accretion of carrying value to redemption value       (3,351,344)
Net income       3,187,222
Issuance of Class B ordinary shares to Sponsor       0
Balance end at Jun. 30, 2026 $ 500 0 240,057 240,557
Balance end (in Shares) at Jun. 30, 2026 5,000,000      
Beginning balance at Mar. 31, 2026 $ 500 0 436,797 437,297
Beginning balance (in Shares) at Mar. 31, 2026 5,000,000      
Accretion of carrying value to redemption value     (1,782,096) (1,782,096)
Net income $ 0 0 1,585,356 1,585,356
Balance end at Jun. 30, 2026 $ 500 $ 0 $ 240,057 $ 240,557
Balance end (in Shares) at Jun. 30, 2026 5,000,000      
[1] Excludes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). 750,000 Class B ordinary shares were forfeited as the underwriter did not exercise the over-allotment option in connection with the Initial Public Offering.
[2] Shares and associated accounts have been retroactively restated to reflect the surrender of 5,544,643 Class B ordinary shares to the Company for no consideration on March 25, 2025. On May 25, 2025, the Company issued to the Sponsor, for no consideration, an aggregate of 1,437,500 founder shares. Shares and associated accounts have been retroactively restated to reflect the issuance of 1,437,500 Class B ordinary shares to the Sponsor for no consideration on May 25, 2025 (see Note 5).